Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.7658
H.R.7658: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced May 3, 2022
- Latest Major Action May 3, 2022
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - May 3, 2022
Bill Summary
This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| May 3, 2022 |
Referred to the House Committee on Energy and Commerce.
|
| May 3, 2022 |
Introduced in the House by Tom O'Halleran (D-Ariz.) |